Recently, DEHP was shown to be associated with atherosclerosis-related cardiovascular disease complication by promoting low-density lipoprotein oxidation and increasing expression of pro-inflammatory mediators, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1 [13]. Here, TNF is linked to cardiovascular disorder.